| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
2e-05 |
| mRNA |
JNK Inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
3e-05 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
5e-05 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
6e-05 |
| mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0001 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0003 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0003 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.21 |
0.0004 |